Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
John J. Strouse, MD, PhD
Associate Professor of Medicine
Department of Pediatrics
Duke University School of Medicine
201 Trent Dr.
Durham, North Carolina, United States
John J. Strouse is currently working as Associate Professor of Medicine in the Department of Pediatrics at Duke University School of Medicine.
He received his medical degree from the Johns Hopkins University School of Medicine and fellowship in Pediatric Hematology from Nci, National Institutes of Health. He also received his Ph.D in clinical investigation from the Johns Hopkins Bloomberg School of Public Health for a series of studies to identify predictors of cognitive function in children with sickle cell disease.
Dr. John J. Strouse’s research has focused on the epidemiology, risk factors, and prevention of the pulmonary and central nervous system complications of sickle cell disease and includes retrospective and prospective cohort studies and clinical trials. His other research interests include the application of large clinical, research, and administrative databases to the study of rare hematological diseases and interventions to improve the quality of and access to care for sickle cell disease. Dr. Strouse has served on the American Society of Hematology Sickle Cell Taskforce and Sickle Cell Pain Guideline Panel and is co-chair of the American Society of Hematology Healthcare Professional Education and Training Work Group.
Education and Training
– Fellow In Pediatric Hematology, Nci, National Institutes of Health, 2001 – 2004
– Fellow In Pediatric Hematology/Oncology, Johns Hopkins University, 2001 – 2004
– Fellow In Hematology, Nhlbi, National Institutes of Health, 2000 – 2004
– Combined Internal Medicine/Pediatrics Residency, University of Rochester, 1996 – 2000
– Ph.D., Johns Hopkins University, 2009
– M.D., Johns Hopkins University School of Medicine, 1996
– Sickle Cell Treatment Demonstration
Pediatric prescriber pratices of hyrdoxyurea in sickle cell diseaseHydroxyurea (HU) has been shown to be ef...
Lewis Hsu, MD, PhDDr. Lewis Hsu is a pediatric hematologis...
Men with sickle cell disease show significant concerns over safety while being treated for vaso-occlusive crises: pr...Background: We undertook a large multisi...
University of Pittsburgh Medical CenterPeople with inherited blood disorders re...
Today’s Faces of Sickle Cell Disease: Swee Lay Thein, MB, BS, FRCP, FRCPath, DScSwee Lay Thein was educated in both Mala...
A Health Note From Dr. Biree Andemariam, SCDAA Chief Medical OfficerWhat You Need to Know About the Coronavi...
Coronavirus Preparedness for People With Chronic Diseaseshttps://www.youtube.com/watch?v=G_JC3vUT...